Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia

Francis J. Giles, Guillermo Garcia-Manero, Jorge E. Cortes, Sharyn D. Baker, Carol B. Miller, Susan M. O'Brien, Deborah A. Thomas, Michael Andreeff, Carol Bivins, Jacques Jolivet, Hagop M. Kantarjian

Research output: Contribution to journalArticlepeer-review

73 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences